- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Quality Metrics in Heart Failure
Panelists discuss how quality metrics should focus on keeping patients out of hospitals through core medical therapies, measuring all-cause hospitalizations and days spent at home in the community, while tracking both process metrics (guideline-directed medical therapy prescriptions, comorbidity management) and outcome metrics (mortality, readmissions, quality of life) with financial incentives through Medicare Accountable Care Organization programs.
Quality measurement in heart failure care encompasses both process and outcome metrics that guide clinical practice and organizational performance. Process metrics focus on evidence-based interventions including prescription rates of core medical therapies (β-blockers, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers/angiotensin receptor‐neprilysin inhibitors, mineralocorticoid receptor antagonists, SGLT2 inhibitors) in eligible patients, control of comorbid conditions like hypertension and diabetes, and utilization of appropriate device therapies and anticoagulation when indicated.
Outcome-based metrics prioritize patient-centered goals including mortality reduction, decreased readmission rates, and improved quality of life. All-cause hospitalization rates are particularly important since patients with heart failure frequently have multiple comorbidities, and readmissions for any cause significantly impact both patient well-being and health care costs. Days spent out of hospital has emerged as a valuable metric, recognizing that time in skilled nursing facilities or other institutional settings may not feel substantially different from hospitalization to patients.
Health care organizations are increasingly adopting comprehensive quality frameworks that align clinical and financial incentives. Value-based care models create strong motivation for quality improvement, as better outcomes directly impact organizational financial performance. The integration of quality metrics into clinical decision-making processes, supported by multidisciplinary care teams and advanced practice providers, represents a systematic approach to achieving sustained improvements in heart failure care delivery and patient outcomes.
